Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Correlation of PVR gene expression, serum levels, serum amylase, and urinary biomarkers with clinical characteristics in multiple myeloma cases (n = 50)

From: Prognostic and diagnostic value of PVR gene and protein levels, serum amylase, and urinary IGFBP-7 and TIMP-2 biomarkers in multiple myeloma

Clinical Characteristics

PVR Gene Expression (rs)

PVR Serum Level (r)

Serum Amylase

(r)

Urine IGFBP-7

(r)

Urine TIMP-2

(r)

Age (years)

−0.124 (p =

−0.084 (p =

0.198 (p = 0.210)

−0.125 (p =

−0.137 (p =

0.393)

0.564)

 

0.345)

0.312)

eGFR

−0.235 (p =

−0.131 (p =

−0.470 (p =

−0.721 (p <

−0.634 (p <

0.101)

0.363)

0.002)*

0.001)*

0.001)*

Creatinine

0.225 (p =

0.216 (p =

0.482 (p = 0.001)*

0.517 (p <

0.526 (p <

0.116)

0.132)

 

0.001)*

0.001)*

Albumin

−0.670 (p <

−0.411 (p =

−0.384 (p =

−0.633 (p <

−0.485 (p =

0.001)*

0.003)*

0.009)*

0.001)*

0.001)*

B2M

0.813 (p <

0.441 (p =

0.247 (p = 0.155)

0.392 (p =

0.401 (p =

0.001)*

0.001)*

 

0.016)*

0.014)*

TLC

−0.370 (p =

0.002 (p =

−0.128 (p = 0.332)

0.158 (p = 0.280)

0.152 (p =

0.008)*

0.988)

  

0.290)

Hb

−0.540 (p <

0.024 (p =

−0.365 (p =

−0.425 (p =

−0.463 (p = 0.001)*

0.001)*

0.869)

0.005)*

0.002)*

PLT

−0.469 (p =

−0.091 (p =

0.127 (p = 0.335)

−0.189 (p =

−0.214 (p =

0.001)*

0.530)

 

0.178)

0.129)

LDH

0.209 (p =

0.288 (p =

0.239 (p = 0.155)

0.330 (p =

0.345 (p =

0.145)

0.043)*

 

0.045)*

0.039)*

Plasma Cell (%)

0.787 (p <

0.520 (p <

0.325 (p = 0.027)*

0.424 (p =

0.438 (p =

0.001)*

0.001)*

 

0.003)*

0.002)*

Serum Amylase

0.375 (p =

0.452 (p =

 

0.215 (p = 0.114)

0.215 (p =

0.015)*

0.002)*

  

0.115)

M Protein

0.432 (p =

0.316 (p =

0.210 (p = 0.087)

0.284 (p = 0.055)

0.261 (p =

0.002)*

0.018)*

  

0.056)

Urine LC λ

−0.134 (p =

−0.116 (p =

−0.045 (p = 0.812)

−0.210 (p =

−0.225 (p =

0.342)

0.409)

 

0.153)

0.139)

Urine LC κ

0.145 (p = 0.309)

0.132 (p = 0.352)

0.089 (p = 0.554)

0.194 (p = 0.178)

0.185 (p = 0.197)

Urine IGFBP-7

0.251(p = 0.079)

−0.054 (p = 0.712)

0.220 (p = 0.143)

  

Urine TIMP-2

0.262(p = 0.067)

0.234 (p = 0.101)

0.238 (p = 0.158)

  
  1. eGFR estimated glomerular filtration rate, B2M β2-microglobulin, TLC Total Leucocyte Count, Hb Hemoglobin, PLT Platelets, LDH Lactate dehydrogenase, Urine LC λ Urine light chain lambda, Urine LC κ Urine light chain kappa, rs Spearman coefficient, r Pearson coefficient
  2. *Statistically significant at p ≤ 0.05